Quick answer: Mimosa hostilis (also called Mimosa tenuiflora, or jurema preta) is a Brazilian tree whose root bark has a long history in traditional wound care, dye-making, and folk remedies. Peer-reviewed research over the last two decades has confirmed several of these uses — particularly wound healing, antioxidant activity, and antimicrobial effects — and traced them to specific compounds: arabinogalactan polysaccharides, condensed tannins, flavonoids, and triterpene saponins. Formal clinical trials in humans remain limited, and most findings are still at the cell-culture or animal-model stage.
A Plant With a Long Ethnobotanical Record
Mimosa tenuiflora is native to the semi-arid Caatinga region of northeastern Brazil, where it’s known locally as jurema preta, and to parts of Mexico, where it’s called tepezcohuite. For generations, communities in both regions have used the reddish-brown inner bark topically — ground into a powder and applied to burns, cuts, and skin irritation — and the tree itself has served practical roles as firewood, animal fodder, and a source of natural dye and tannin for leather.
Modern phytochemistry research treats this traditional use as a starting point rather than a conclusion. Researchers working with chromatography and spectroscopy have been isolating and characterizing the bark’s constituent molecules to figure out which ones are actually responsible for the effects reported in traditional practice — and whether those effects hold up under controlled conditions.
What’s Actually in the Bark
Analytical work spanning several research groups has identified a fairly consistent chemical picture across M. tenuiflora bark extracts:
- Condensed tannins, which give the bark its dark color and are linked to its long use in leather tanning and dye
- Flavonoids, including flavonols and flavanones, some of which have been isolated from propolis that bees produce using resin gathered from the plant’s young shoots
- Arabinogalactan polysaccharides, a class of complex sugars specifically studied for their role in skin repair
- Triterpene saponins, including lupeol, a compound separately studied for anti-inflammatory activity in other plant sources
- Steroids and terpenoids present in smaller quantities
Researchers rely on techniques like high-performance liquid chromatography (HPLC), gas chromatography–mass spectrometry (GC-MS), and nuclear magnetic resonance (NMR) spectroscopy to separate and confirm these compounds, since bark extracts are chemically complex mixtures rather than a single active ingredient.
Where the Evidence Is Strongest: Wound Healing
The best-documented modern finding on M. tenuiflora concerns skin repair. A study published in the Journal of Ethnopharmacology isolated arabinogalactan fractions from the bark and tested them on human dermal fibroblasts — the cells responsible for producing collagen and rebuilding skin tissue. The extract measurably increased fibroblast activity, giving a plausible mechanistic explanation for centuries of topical use on burns and wounds. Follow-up material-science work has explored incorporating the bark into chitosan-based films intended as wound dressings, aiming to combine the plant’s bioactivity with a delivery format suited to clinical use.
Antioxidant and Antimicrobial Signals
Broader reviews of the genus Mimosa — which includes roughly 400 species, of which M. tenuiflora and M. pudica are the most studied — consistently report two things about this group of plants: notable antioxidant capacity, largely attributed to their flavonoid and tannin content, and antimicrobial activity against a range of bacterial and fungal strains in lab testing. These findings track with the plant’s traditional use for skin infections and irritation, though as with most botanical research, the jump from “active in a petri dish” to “effective and standardized as a product” requires additional pharmacokinetic and clinical work that hasn’t yet been done at scale.
An Important Caveat: Toxicity in Livestock
Any accurate account of this plant needs to include a well-established finding that’s easy to miss if you only read enthusiast sources: M. tenuiflora has documented teratogenic and abortive effects in grazing ruminants. Multiple studies out of Brazil’s semi-arid ranching regions have linked ingestion of the plant’s leaves and seeds to birth defects and pregnancy loss in goats, sheep, and cattle — a serious agricultural concern that has driven a fair amount of the plant’s veterinary research. This doesn’t necessarily translate directly to topical human use of the bark, but it’s a reminder that “traditional” and “natural” aren’t synonyms for “safe in every form and route of exposure,” and that toxicology is compound- and context-specific.
Commercial and Sustainability Considerations
Because the bark has real value for tanning, dye, and cosmetic formulation, sourcing has become a practical concern. Ethnobotanists and industry researchers increasingly emphasize partnerships with the Indigenous and rural communities who have cultivated knowledge of the plant, alongside sustainable harvesting practices that avoid over-stripping bark from wild populations in the Caatinga, a biome that is itself under conservation pressure. Botanical identity verification (to confirm bark is genuinely M. tenuiflora and not a substitute species) and standard quality-control testing for contaminants are also standard practice for any commercial extract intended for cosmetic or topical products.
Where Research Is Headed
Current academic interest is moving in a few directions:
- Formulation science — testing whether encapsulating bark extracts (for example, in lipid-based carriers) improves stability and absorption compared to raw powder
- Systematic pharmacological review — several 2020s-era papers have specifically catalogued the preclinical (cell and animal) evidence base for M. tenuiflora, which helps identify where solid data exists and where claims are still unsupported
- Comparative genus studies — situating M. tenuiflora within the wider Mimosa genus to see which pharmacological effects are shared across species and which are unique to this one
None of this has yet produced completed human clinical trials for a standardized M. tenuiflora product, which remains the clearest gap between the traditional-use evidence and a fully substantiated modern therapeutic claim.
Frequently Asked Questions
Is Mimosa hostilis the same as Mimosa tenuiflora?
Yes. Mimosa hostilis is an older or informal name still used commercially; Mimosa tenuiflora (Willd.) Poir. is the currently accepted scientific name.
What is Mimosa hostilis bark traditionally used for?
Topical wound and burn care, skin conditioning, and as a source of tannin for dye and leather.
Does research support its wound-healing reputation?
Yes, to a meaningful degree. Isolated arabinogalactan compounds from the bark have been shown in lab studies to boost activity in the skin cells responsible for wound repair.
Is Mimosa hostilis safe?
Topical folk use has a long history, but the plant is documented as toxic to grazing livestock in specific forms (leaves and seeds, ingested), and rigorous human safety data for extracts is still limited. Anyone considering a product made from it should look for standardized, quality-tested extracts and consult a healthcare provider for any therapeutic use.
Is Mimosa hostilis used in skincare?
Yes — its tannins and polysaccharides are of active interest to cosmetic formulators for anti-aging and skin-conditioning products, building on its traditional role in burn and wound care.
Sources
- Zippel, J., Deters, A., & Hensel, A. (2009). Arabinogalactans from Mimosa tenuiflora bark as active principles for wound-healing properties. Journal of Ethnopharmacology, 124(3), 391–396. https://doi.org/10.1016/j.jep.2009.05.034
- de Souza, R. S. O., de Albuquerque, U. P., Monteiro, J. M., & de Amorim, E. L. C. (2008). Jurema-Preta (Mimosa tenuiflora [Willd.] Poir.): a review of its traditional use, phytochemistry and pharmacology. Brazilian Archives of Biology and Technology, 51(5), 937–947. https://doi.org/10.1590/S1516-89132008000500010
- Lopes, C. M. I., et al. (2021). Phytochemistry and teratogenic potential of Mimosa tenuiflora (Willd.) Poir. (Fabaceae) in ruminants: A systematic review. Toxicon, 195, 78–85. https://doi.org/10.1016/j.toxicon.2021.03.010
- Kadhim, E. J., et al. (2022). Phytochemistry and Diverse Pharmacology of Genus Mimosa: A Review. Biomolecules (PMC8773851). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773851/
- Valencia-Gómez, L. E., et al. Chitosan/Mimosa tenuiflora films as potential cellular patch for skin regeneration. Materials Science and Engineering: C.
- Assessing Chemical Constituents of Mimosa caesalpiniifolia Stem Bark (comparative genus data). PMC6272184. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272184/
